SIETES :: 92257 citas

Añadir las seleccionadas a mis citas; si se ha deseleccionado alguna, se eliminara de mis citas

Actualizar mis citas con la selección

1 a 20 de 22398 siguiente >>

Presentar resultados

Seleccionar todas

1.

Cita con resumen

Darrow JJ, Avorn J, Kesselheim AS. The FDA breakthrough-drug designation - Four years of experience. N Engl J Med 2018;378:16 de abril. [Ref.ID 102515]

2.

Enlace a cita original

Cita con resumen

Zheng SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, Francis D, Oliver N, Meeran K. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA 2018;319:17 de abril. [Ref.ID 102513]

3.

Enlace a cita original

Cita con resumen

Lane S, Lynn E, Shakir S. Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012. BMJ Open 2018;8:e019759. [Ref.ID 102510]

4.

Cita con resumen

Anónimo. Hallucinations and pimavanserin (NUPLAZID), a new kind of drug for psychosis. ISMP Quarter Watch 2018:6. [Ref.ID 102509]

5.

Cita con resumen

Benefits NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers. A randomized clinical trial. JAMA Intern Med 2018:9 de abril. [Ref.ID 102506]

6.

Cita con resumen

Tsujimoto T, Kajio H, Shapiro MF, Sugiyama T. Risk of all-cause mortality in diabetic patients taking ß-blockers. Mayo Clin Proc 2017;93:409-18. [Ref.ID 102505]

7.

Cita con resumen

Thayer K. Synthetic pot warning issued as number of users experiencing severe bleeding jumps to 32. Chicago Tribune 2018:1. [Ref.ID 102490]

8.

Enlace a cita original

Cita con resumen

Moore PA, Ziegler KM, Lipman RD, Aminoshariae A, Carrasco-Labra A, Mariotti A. Benefits and harms associated with analgesic medications used in the management of acute dental pain. The Journal of the American Dental Association 2018;149:abril. [Ref.ID 102481]

9.

Enlace a cita original

Tiene citas relacionadas

Cita con resumen

Cipriani A, Furukwa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. . Lancet 2018;391:7 de abril. [Ref.ID 102476]

10.

Cita con resumen

Loftus P. Biogen and Abbvie take Multiple sclerosis drug off market. Wall St J 2018:1. [Ref.ID 102466]

11.

Cita con resumen

Pennell PB. Antiepileptic drugs in pregnancy — Quick decisions with long-term consequences. JAMA Neurology 2018:1. [Ref.ID 102464]

12.

Cita con resumen

Elkjær LS, Bech BH, Sun Y, Laursen TM, Christensen J. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children. JAMA Neurology 2018:1. [Ref.ID 102463]

13.

Cita con resumen

Branswell H. Salmonella outbreak in 20 states linked to kratom consumption. STAT 2018:3. [Ref.ID 102462]

14.

Cita con resumen

Anónimo. Many lawsuits concerning diabetes drug saxagliptin transferred to US district judge in Kentucky. DIA Daily 2018:5. [Ref.ID 102461]

15.

Cita con resumen

Anónimo. FDA received more reports last year of “rare, frightening side effect” of aflibercept. DIA Daily 2018:4. [Ref.ID 102459]

16.

Cita con resumen

Anónimo. Soluciones de hidroxietil-almidón: recomendación de suspensión de comercialización. Recomendaciones del Comité para la Evaluación de Riesgos en Farmacovigilancia europeo (PRAC). Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2018:15 de enero. [Ref.ID 102444]

17.

Cita con resumen

Anónimo. Hungarian drugmaker says EMA will decide on ulipristal in first half of this year. DIA Daily 2018:4. [Ref.ID 102443]

18.

Cita con resumen

Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med 2018:2 de enero. [Ref.ID 102440]

19.

Cita con resumen

Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ. Outcomes of dabigatran and warfarin for atrial fibrillation in contemporary practice: a retrospective cohort study. Ann Intern Med 2017;167:845-54. [Ref.ID 102196]

20.

Cita con resumen

Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]

Seleccionar todas

Añadir las seleccionadas a mis citas; si se ha deseleccionado alguna, se eliminara de mis citas

Actualizar mis citas con la selección

1 a 20 de 22398 siguiente >>